February 22, 2018 / 9:49 PM / 10 months ago

BRIEF-Collegium Filed Patent Infringement Lawsuit Against Teva Pharma USA

Feb 22 (Reuters) - Collegium Pharmaceutical Inc:

* COLLEGIUM PHARMA SAYS FILED PATENT INFRINGEMENT LAWSUIT IN U.S. DISTRICT COURT FOR DISTRICT OF DELAWARE AGAINST TEVA PHARMACEUTICALS USA INC

* COLLEGIUM PHARMA SAYS LAWSUIT WAS FILED IN RESPONSE TO A PARAGRAPH IV CERTIFICATION CO RECEIVED FROM TEVA - SEC FILING

* COLLEGIUM PHARMA SAYS CERTIFICATION STATED TEVA SUBMITTED ANDA TO U.S. FDA FOR GENERIC VERSION OF XTAMPZA ER (OXYCODONE) EXTENDED-RELEASE CAPSULES Source: (bit.ly/2EVJmhH) Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below